1.91 (-%)
As of Nov 21, 2024
Source:
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on the development and commercializationof a novel class of specifically targeted polyclonal antibodies that we believe can address significant unmet medical needs.
Country | United States |
Headquarters | carlton south |
Phone Number | 61 03 9824 5254 |
Industry | manufacturing |
CEO | Mr. Steven Lydeamore |
Website | www.Immuron.com |